Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 3325 of 3499 entries
View as:
Phase: N/A Priority: Normal
NCT ID: NCT00923052 Org: User:
Start: 02/09/09 End: 05/07/15 Due: 05/07/16
Phase: N/A Priority: Normal
NCT ID: NCT00001443 Org: User:
Start: 07/31/95 End: 10/31/00 Due: 10/31/01
Phase: N/A Priority: Normal
NCT ID: NCT00340223 Org: User:
Start: 09/30/05 End: 09/30/07 Due: 09/30/08
Phase: N/A Priority: Normal
NCT ID: NCT00077545 Org: User:
Start: 01/31/04 End: - Due: -
Phase: N/A Priority: Normal
NCT ID: NCT00062166 Org: User:
Start: 04/11/03 End: 11/29/17 Due: 11/29/18
Phase: N/A Priority: Normal
NCT ID: NCT00340847 Org: User:
Start: 08/09/01 End: 05/19/10 Due: 05/19/11
Phase: N/A Priority: Normal
NCT ID: NCT02090933 Org: User:
Start: 03/31/04 End: 12/31/04 Due: 12/31/05
Phase: N/A Priority: Normal
NCT ID: NCT00052949 Org: User:
Start: 05/31/03 End: - Due: -
Phase: N/A Priority: Normal
NCT ID: NCT00563290 Org: User:
Start: 11/30/07 End: 10/31/14 Due: 10/31/15
Phase: N/A Priority: Normal
NCT ID: NCT00070239 Org: User:
Start: 08/31/03 End: - Due: -
Phase: N/A Priority: Normal
NCT ID: NCT00703300 Org: User:
Start: 06/30/08 End: 10/31/14 Due: 10/31/15
Phase: N/A Priority: Normal
NCT ID: NCT00005967 Org: User:
Start: 08/31/00 End: - Due: -
Phase: N/A Priority: Normal
NCT ID: NCT04674228 Org: User:
Start: 05/07/21 End: 05/17/22 Due: 05/17/23
Phase: N/A Priority: Normal
NCT ID: NCT02572453 Org: User:
Start: 04/04/16 End: 03/18/21 Due: 03/18/22
Phase: N/A Priority: Normal
NCT ID: NCT00026091 Org: User:
Start: 09/30/01 End: - Due: -
Phase: N/A Priority: Normal
NCT ID: NCT00179309 Org: User:
Start: 09/30/05 End: 10/31/13 Due: 10/31/14
Phase: N/A Priority: Normal
NCT ID: NCT01935934 Org: User:
Start: 05/08/13 End: 10/24/24 Due: 10/24/25
Phase: N/A Priority: Normal
NCT ID: NCT02101788 Org: User:
Start: 02/27/14 End: 10/11/25 Due: 10/11/26
Phase: N/A Priority: Normal
NCT ID: NCT00450879 Org: User:
Start: 01/31/07 End: 09/30/11 Due: 09/30/12